AfricaRegulatory

African Pharmaceutical Regulatory Intelligence

MarketsSign up free
🇿🇦

Irinotecan Hydrochloride Trihydrate in South Africa

10 products registered with SAHPRA — 8 active

Brand / ProductReg. No.HolderStatusExpires
IRITERO 40 mg/2 ml56/26/0829Hetero Drugs South Africa (Pty) Ltdactive11 Jul 2028
IRITERO 100 mg/5 ml56/26/0830Hetero Drugs South Africa (Pty) Ltdactive11 Jul 2028
IRITERO 300 mg/5 ml56/26/0831Hetero Drugs South Africa (Pty) Ltdactive11 Jul 2028
CAROHET 40 mg/2 ml56/26/0832.829Hetero Drugs South Africa (Pty) Ltdactive11 Jul 2028
CAROHET 100 mg/5 ml56/26/0833.830Hetero Drugs South Africa (Pty) Ltdactive11 Jul 2028
CAROHET 300 mg/15 ml56/26/0834.831Hetero Drugs South Africa (Pty) Ltdactive11 Jul 2028
IRENAX 4041/26/0030Sandoz South Africa (Pty) Ltdsuspended21 Jan 2022
IRENAX 10041/26/0031Sandoz South Africa (Pty) Ltdsuspended21 Jan 2022
SANDOZ IRINOTECAN 4041/26/0028Oethmaan Biosims (Pty) Ltdactive1 Jan 1900
SANDOZ IRINOTECAN 10041/26/0029Oethmaan Biosims (Pty) Ltdactive1 Jan 1900

Irinotecan Hydrochloride Trihydrate — SAHPRA Registration Details

SAHPRA (South Africa) has 10 registered products containing Irinotecan Hydrochloride Trihydrate, of which 8 are currently active. Data is sourced directly from the official SAHPRA drug register and refreshed daily.

Track Irinotecan Hydrochloride Trihydrate registration expiry dates, monitor competitor approvals, and receive alerts when registration status changes. Create a free account to set up portfolio monitoring.